Emma Dunn

Emma Dunn is a Writing, Literature, and Publishing student at Emerson College in Boston. Besides writing for Type2Nation and Insulin Nation, she also writes for the online publication, The Odyssey.
Treatment

Pot Tested as Treatment for Neuropathy Pain

It helped ease the pain for participants in a small study.

Read More »
Treatment

FDA Approves Metformin For Some with Kidney Issues

A review of data suggests it’s safe for those with mild kidney impairment.

Read More »
Treatment

Which Diabetes Treatment Works Best?

A recent review suggests metformin is the most popular for a reason, but newer drugs may challenge metformin’s market dominance.

Read More »
Treatment

What are Sulfonylureas?

Get to know this popular blood-sugar-lowering drug.

Read More »
Treatment

What Are Thiazolidinediones?

We take a closer look at a drug that helps combat insulin resistance. It comes with some risks, however.

Read More »
Treatment

FDA Slower to Approve New Medical Devices Than Drugs

A study finds the agency’s testing protocol for blockbuster devices slows down the process and leads to unnecessary testing.

Read More »
Living

Social Media to Treat Type 1 Diabetes?

New guidelines suggest that young people with Type 1 who discuss their diabetes online stay engaged in their self-care.

Read More »
Treatment

Life Expectancy Increases for People with Type 1

An Australian study finds people with Type 1 are living longer, but not as long as the average population.

Read More »
Treatment

Why to Plan Pregnancy with Your Diabetes Health Team

A pair of studies suggests that attending a pre-conception clinic can lead to a safer pregnancy for women with Type…

Read More »
Research

Testing Metformin to Prevent Type 1 Diabetes

In a major trial, researchers are attempting to keep beta cells working longer in children at risk of Type 1…

Read More »
Treatment

Take Our Type 1 Diabetes Trivia Quiz!

And enter for a chance to win a Starbucks giftcard.

Read More »
Treatment

Dexcom Recalls G4 and G5 CGMs

The recall is being undertaken because alarms in Dexcom’s CGM devices are reported to be faulty.

Read More »
Treatment

Study Highlights Risk of DKA After Surgery

Researchers find that 25% of people with Type 1 suffered from moderate to severe diabetic ketoacidosis after bariatric surgery.

Read More »
Treatment

Lucentis Bests Laser Eye Surgery in Trial

A trial reveals that Lucentis may be better than laser eye surgery at treating proliferative diabetic retinopathy, which causes blindness.

Read More »
Living

Scholarships for Young Minds with Type 1

The Diabetes Scholars Foundation has provided opportunities for thousands.

Read More »
Treatment

Lilly CEO Defends Profits Made on Insulin

Lilly CEO says insulin price increases are necessary to fund research.

Read More »
Research

Nasal Glucagon Proves Effective in Latest Trial

It performed nearly as well as injectable glucagon in staving off hypoglycemia.

Read More »
Treatment

DKA Rate During Hospitalization is Too High

A recent audit of UK hospitals suggests that too many patients with diabetes receive substandard blood sugar control.

Read More »
Treatment

Medtronic to Build Pump Factory for Chinese Market

The move comes as health care companies rush to provide treatment options for the growing diabetes epidemic in China.

Read More »
Back to top button